Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deerfield Management Opts For More Private Investment And A New Public Face

Jan 07 2013

Related Content

Deerfield To NitroMed: Not So Fast, Not So Cheap

Dec 04 2008

<em>Cometriq</em> Thyroid Approval May Open Door For Use In Prostate Cancer

Dec 10 2012

The Future Of Private Biotech Investment: A Q&A With Jonathan Leff

Dec 10 2012

Related Companies

NitroMed, Inc.

Archemix Corp.

Arbor Pharmaceuticals, LLC

Tesaro, Inc.

Eisai Co., Ltd.

inRegen

Pacific Biosciences of California, Inc.

Avadel Pharmaceuticals plc

Genetix Biotherapeutics

Foundation Medicine, Inc.

Melinta Therapeutics, Inc.

Talon Therapeutics, Inc.

ISTA Pharmaceuticals, Inc.

Bausch Health Companies Inc.

Arena Pharmaceuticals, Inc.

Array BioPharma, Inc.

Insulet Corporation

Bristol Myers Squibb Company

YM BioSciences Inc.

Gilead Sciences, Inc.

Somaxon Pharmaceuticals, Inc.

Currax Pharmaceuticals LLC

Bausch Health Companies Inc.

Exelixis, Inc.

Sanofi

Additional Topics

Business Strategies Clinical Trials Deals BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window